GSK to buy efimosfermin in $2 billion deal

breakingthenews.net/Article/GSK-to-buy-efimosfermin-in-dollar2-billion-deal/64105557

GSK plc announced on Wednesday in a statement that it entered into an agreement with Boston Pharmaceuticals Inc. to acquire the latter's lead asset, efimosfermin alfa."Efimosfermin is a phase III-read...

This story appeared on breakingthenews.net, 2025-05-14 06:29:00.
The Entire Business World on a Single Page. Free to Use →